This study investigates the use of CNSI-Fe for advanced solid tumors. CNSI-Fe is being explored for its potential effects on these tumors.
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CNSI-Fe when injected directly into tumors.
- Who can participate: Adults aged 18 to 80 with advanced solid tumors, where standard therapy is ineffective, can participate. Participants must have suitable injectable lesions and meet specific health criteria.
- Study details: Participants will receive CNSI-Fe injections into tumors. A placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used for comparison.